Stroke Prevention in Atrial Fibrillation in Patients With Chronic Kidney Disease

Circulation. 2016 Apr 12;133(15):1512-5. doi: 10.1161/CIRCULATIONAHA.115.018549.
No abstract available

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged
  • Anticoagulants / adverse effects
  • Anticoagulants / pharmacokinetics
  • Anticoagulants / therapeutic use*
  • Aspirin / adverse effects
  • Aspirin / therapeutic use
  • Atrial Fibrillation / complications*
  • Clinical Trials as Topic
  • Creatinine / blood
  • Diabetes Complications
  • Drugs, Investigational / adverse effects
  • Drugs, Investigational / pharmacokinetics
  • Drugs, Investigational / therapeutic use
  • Europe / epidemiology
  • Female
  • Heart Failure / complications
  • Hemorrhage / chemically induced
  • Hemorrhage / epidemiology
  • Humans
  • Hypertension / complications
  • Myocardial Infarction / prevention & control
  • North America / epidemiology
  • Observational Studies as Topic
  • Pyrazoles / adverse effects
  • Pyrazoles / pharmacokinetics
  • Pyrazoles / therapeutic use*
  • Pyridones / adverse effects
  • Pyridones / pharmacokinetics
  • Pyridones / therapeutic use*
  • Registries
  • Renal Insufficiency, Chronic / complications*
  • Renal Insufficiency, Chronic / metabolism
  • Severity of Illness Index
  • Stroke / epidemiology
  • Stroke / etiology
  • Stroke / prevention & control*
  • Tachycardia / complications
  • Thrombophilia / drug therapy*
  • Thrombophilia / etiology
  • Treatment Outcome
  • Warfarin / adverse effects
  • Warfarin / therapeutic use

Substances

  • Anticoagulants
  • Drugs, Investigational
  • Pyrazoles
  • Pyridones
  • apixaban
  • Warfarin
  • Creatinine
  • Aspirin